{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:18:51Z","timestamp":1772165931575,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"DOI":"10.1186\/s12893-025-03374-x","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T23:34:59Z","timestamp":1767742499000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Characteristics of late recurrences after hepatectomy for perihilar cholangiocarcinoma: a single-center cohort study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9688-4956","authenticated-orcid":false,"given":"Hideaki","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4221-0236","authenticated-orcid":false,"given":"Shuichi","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Iseki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichiro","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Yoshimachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Kusaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4147-8081","authenticated-orcid":false,"given":"Mitsuhiro","family":"Shimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Douchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9744-5537","authenticated-orcid":false,"given":"Takayuki","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimpei","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6436-5477","authenticated-orcid":false,"given":"Masamichi","family":"Mizuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Masamune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2145-6416","authenticated-orcid":false,"given":"Michiaki","family":"Unno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"issue":"8","key":"3374_CR1","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1111\/liv.14856","volume":"41","author":"AM van Keulen","year":"2021","unstructured":"van Keulen AM, Franssen S, van der Geest LG, et al. Nationwide treatment and outcomes of Perihilar cholangiocarcinoma. Liver Int. 2021;41(8):1945\u201353.","journal-title":"Liver Int"},{"issue":"5","key":"3374_CR2","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/SLA.0000000000005103","volume":"274","author":"M Mueller","year":"2021","unstructured":"Mueller M, Breuer E, Mizuno T, et al. Perihilar Cholangiocarcinoma - Novel benchmark values for surgical and oncological outcomes from 24 expert centers. Ann Surg. 2021;274(5):780\u20138.","journal-title":"Ann Surg"},{"issue":"6","key":"3374_CR3","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","volume":"145","author":"SI Ilyas","year":"2013","unstructured":"Ilyas SI, Gores GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology. 2013;145(6):1215\u201329. https:\/\/doi.org\/10.1053\/j.gastro.2013.10.013. Epub 2013 Oct 15.","journal-title":"Gastroenterology"},{"issue":"2","key":"3374_CR4","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1053\/j.gastro.2008.12.015","volume":"136","author":"JE Everhart","year":"2009","unstructured":"Everhart JE, Ruhl CE. Burden of digestive diseases in the united States part I: overall and upper Gastrointestinal diseases. Gastroenterology. 2009;136(2):376\u201386.","journal-title":"Gastroenterology"},{"issue":"1","key":"3374_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/hep.24351","volume":"54","author":"GL Tyson","year":"2011","unstructured":"Tyson GL, El-Serag HB. Risk factors for cholangiocarcinoma. Hepatology. 2011;54(1):173\u201384.","journal-title":"Hepatology"},{"issue":"4","key":"3374_CR6","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/00000658-200110000-00010","volume":"234","author":"WR Jarnagin","year":"2001","unstructured":"Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234(4):507\u201317. discussion 517-9.","journal-title":"Ann Surg"},{"issue":"3","key":"3374_CR7","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.surg.2017.03.017","volume":"162","author":"N Kimura","year":"2017","unstructured":"Kimura N, Young AL, Toyoki Y, et al. Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers: outcome analysis and prognostic factors. Surgery. 2017;162(3):500\u201314.","journal-title":"Surgery"},{"issue":"1","key":"3374_CR8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00595-008-3791-x","volume":"39","author":"T Machimoto","year":"2009","unstructured":"Machimoto T, Doi R, Ogawa K, Masui T, Seo S, Uemoto S. Abdominal wall recurrence of hilar bile duct cancer 12 years after a curative resection: report of a case. Surg Today. 2009;39(1):72\u20136.","journal-title":"Surg Today"},{"issue":"5","key":"3374_CR9","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s00534-005-1096-7","volume":"13","author":"T Sasaki","year":"2006","unstructured":"Sasaki T, Kondo S, Ambo Y, et al. Local recurrence at hepaticojejunostomy 9 years after resection of bile duct cancer with superficial flat spread. J Hepatobiliary Pancreat Surg. 2006;13(5):458\u201362.","journal-title":"J Hepatobiliary Pancreat Surg"},{"issue":"5","key":"3374_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/gastro\/goz012","volume":"7","author":"DZ Peng","year":"2019","unstructured":"Peng DZ, Lu J, Li B, et al. A simple scoring system to predict early recurrence of Bismuth-Corlette type IV Perihilar cholangiocarcinoma. Gastroenterol Rep (Oxf). 2019;7(5):345\u201353.","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"2","key":"3374_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s13691-020-00400-y","volume":"9","author":"C Mitsuura","year":"2020","unstructured":"Mitsuura C, Okabe H, Yamashita YI, et al. A case of chest wall recurrence of hilar cholangiocarcinoma 10 years after R1 surgery with positive ductal margin of carcinoma in situ. Int Cancer Conf J. 2020;9(2):77\u201381.","journal-title":"Int Cancer Conf J"},{"issue":"6","key":"3374_CR12","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s12328-013-0432-8","volume":"6","author":"Y Ota","year":"2013","unstructured":"Ota Y, Matsuyama R, Taniguchi K, et al. Solitary rib recurrence of hilar cholangiocarcinoma 10 years after resection: report of a case. Clin J Gastroenterol. 2013;6(6):485\u20139.","journal-title":"Clin J Gastroenterol"},{"key":"3374_CR13","doi-asserted-by":"publisher","first-page":"13111","DOI":"10.2147\/CMAR.S289094","volume":"12","author":"J Zhao","year":"2020","unstructured":"Zhao J, Zhang W, Zhang J, et al. Independent risk factors of early recurrence after curative resection for Perihilar cholangiocarcinoma: adjuvant chemotherapy May be beneficial in early recurrence subgroup. Cancer Manag Res. 2020;12:13111\u201323.","journal-title":"Cancer Manag Res"},{"issue":"20","key":"3374_CR14","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.3390\/cancers16203463","volume":"16","author":"R Margies","year":"2024","unstructured":"Margies R, Gr\u00f6ger LK, Straub BK, Bartsch F, Lang H. Influence of perineural (Pn), lymphangio (L) and vascular (V) invasion on survival after resection of Perihilar cholangiocarcinoma. Cancers (Basel). 2024;16(20):3463.","journal-title":"Cancers (Basel)"},{"issue":"11","key":"3374_CR15","doi-asserted-by":"publisher","first-page":"106982","DOI":"10.1016\/j.ejso.2023.07.008","volume":"49","author":"Y Tian","year":"2023","unstructured":"Tian Y, Wen N, Li B, et al. A meta-analysis of prognostic factors for early recurrence in Perihilar cholangiocarcinoma after curative-intent resection. Eur J Surg Oncol. 2023;49(11):106982.","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"3374_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/SLA.0b013e3182708b57","volume":"258","author":"M Nagino","year":"2013","unstructured":"Nagino M, Ebata T, Yokoyama Y, et al. Evolution of surgical treatment for Perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg. 2013;258(1):129\u201340.","journal-title":"Ann Surg"},{"issue":"4","key":"3374_CR17","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/jhbp.914","volume":"28","author":"M Nagino","year":"2021","unstructured":"Nagino M, Ebata T, Yokoyama Y, et al. Hepatopancreatoduodenectomy with simultaneous resection of the portal vein and hepatic artery for locally advanced cholangiocarcinoma: Short- and long-term outcomes of superextended surgery. J Hepatobiliary Pancreat Sci. 2021;28(4):376\u201386.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"2","key":"3374_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313.","journal-title":"Ann Surg"},{"issue":"10372","key":"3374_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0140-6736(22)02038-4","volume":"401","author":"K Nakachi","year":"2023","unstructured":"Nakachi K, Ikeda M, Konishi M, et al. Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet. 2023;401(10372):195\u2013203.","journal-title":"Lancet"},{"issue":"9","key":"3374_CR20","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1007\/s00268-018-4530-0","volume":"42","author":"XF Zhang","year":"2018","unstructured":"Zhang XF, Beal EW, Chakedis J, et al. Defining early recurrence of hilar cholangiocarcinoma after Curative-intent surgery: A Multi-institutional study from the US extrahepatic biliary malignancy consortium. World J Surg. 2018;42(9):2919\u201329.","journal-title":"World J Surg"},{"issue":"2","key":"3374_CR21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/nm0295-149","volume":"1","author":"L Holmgren","year":"1995","unstructured":"Holmgren L, O\u2019Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med. 1995;1(2):149\u201353.","journal-title":"Nat Med"},{"issue":"2","key":"3374_CR22","first-page":"285","volume":"17","author":"Y Takahashi","year":"2000","unstructured":"Takahashi Y, Mai M, Taguchi T, Urushizaki I, Nishioka K. Prolonged stable disease effects survival in patients with solid gastric tumor: analysis of phase II studies of doxifluridine. Int J Oncol. 2000;17(2):285\u20139.","journal-title":"Int J Oncol"},{"issue":"7","key":"3374_CR23","first-page":"2162","volume":"62","author":"GN Naumov","year":"2002","unstructured":"Naumov GN, MacDonald IC, Weinmeister PM, et al. Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res. 2002;62(7):2162\u20138.","journal-title":"Cancer Res"},{"issue":"11","key":"3374_CR24","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1007\/s00268-017-4068-6","volume":"41","author":"B Zheng","year":"2017","unstructured":"Zheng B, Ohuchida K, Yan Z, Okumura T, Ohtsuka T, Nakamura M. Primary recurrence in the lung is related to favorable prognosis in patients with pancreatic cancer and postoperative recurrence. World J Surg. 2017;41(11):2858\u201366.","journal-title":"World J Surg"},{"issue":"12","key":"3374_CR25","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1158\/2159-8290.CD-21-0634","volume":"11","author":"EJ Moding","year":"2021","unstructured":"Moding EJ, Nabet BY, Alizadeh AA, Diehn M. Detecting liquid remnants of solid tumors: Circulating tumor DNA minimal residual disease. Cancer Discov. 2021;11(12):2968\u201386.","journal-title":"Cancer Discov"},{"issue":"6","key":"3374_CR26","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1200\/JCO.21.01929","volume":"40","author":"B Pellini","year":"2022","unstructured":"Pellini B, Chaudhuri AA. Circulating tumor DNA minimal residual disease detection of Non-Small-Cell lung cancer treated with curative intent. J Clin Oncol. 2022;40(6):567\u201375.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3374_CR27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.7150\/thno.21945","volume":"8","author":"C He","year":"2018","unstructured":"He C, Zheng S, Luo Y, Wang B. Exosome theranostics: biology and translational medicine. Theranostics. 2018;8(1):237\u201355. https:\/\/doi.org\/10.7150\/thno.21945. PMID: 29290805; PMCID: PMC5743472.","journal-title":"Theranostics"},{"issue":"1","key":"3374_CR28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/path.6265","volume":"263","author":"Y Omori","year":"2024","unstructured":"Omori Y, Aoki S, Ono Y, et al. Clonal analysis of metachronous double biliary tract cancers. J Pathol. 2024;263(1):113\u201327.","journal-title":"J Pathol"},{"issue":"3","key":"3374_CR29","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1007\/s00259-023-06478-9","volume":"51","author":"T Watabe","year":"2024","unstructured":"Watabe T, David IR, Kimura T, et al. Epithelioid granuloma mimicking lung cancer showed intense uptake on [18F]FAPI-74 PET. Eur J Nucl Med Mol Imaging. 2024;51(3):930\u20131.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"3374_CR30","doi-asserted-by":"publisher","first-page":"EVIDoa2200015","DOI":"10.1056\/EVIDoa2200015","volume":"1","author":"DY Oh","year":"2022","unstructured":"Oh DY, Ruth He A, Qin S, et al. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer. NEJM Evid. 2022;1(8):EVIDoa2200015.","journal-title":"NEJM Evid"},{"issue":"10391","key":"3374_CR31","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","volume":"401","author":"RK Kelley","year":"2023","unstructured":"Kelley RK, Ueno M, Yoo C, et al. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023;401(10391):1853\u201365.","journal-title":"Lancet"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12893-025-03374-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-025-03374-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-025-03374-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T11:16:26Z","timestamp":1770203786000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12893-025-03374-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3374"],"URL":"https:\/\/doi.org\/10.1186\/s12893-025-03374-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7306398\/v1","asserted-by":"object"}]},"ISSN":["1471-2482"],"issn-type":[{"value":"1471-2482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was conducted in accordance with the ethical standards outlined in the Declaration of Helsinki and was approved by the Institutional Review Board of Tohoku University (approval number: 2024-1-668). Written informed consent was obtained from all patients regarding the use of their clinical data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}